Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study

NCT01174290 is registered in ClinicalTrials.gov with Northeastern University as lead sponsor.

NCT NCT01174290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01174290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study
Lead sponsor
Northeastern University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2014
Enrollment
68 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

subsyndromal delirium